The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Toll-like Receptor Status in Obesity and Metabolic Syndrome: A Translational Perspective
Open accessAbstract
CONTEXT: The prevalence of both obesity and metabolic syndrome (MetS) is increasing at alarming rates globally. Both predispose to diabetes, cardiovascular disease, fatty liver disease, obstructive sleep apnea, and certain cancers. Understanding the mechanisms contributing to increased cardiometabolic risk in obesity and MetS is of utmost importance. EVIDENCE ACQUISITION: For this review, we performed a detailed literature search on PubMed of all publications related to Toll-like receptors (TLRs) and obesity and MetS for the last 20 years. EVIDENCE SYNTHESIS: The TLRs are well-characterized immune receptors that enhance inflammation. The recognition of pathogen-associated molecular patterns and endogenous (host-derived) ligands released by various cell types triggers activation and expression of TLRs. TLRs, especially TLR2 and TLR4, induce insulin resistance, which is pivotal in the pathogenesis of obesity and MetS. Both obesity and MetS are characterized by low-grade chronic inflammation, possibly triggered by activation of TLR2 and TLR4. TLRs, especially TLR4, are activated by fatty acids and endotoxinemia (a marker of gut permeability), features of both obesity and MetS, resulting in activation of nuclear factor-κB and increased release of inflammatory biomediators such as IL-6, IL-1β, TNF-α, and monocyte chemotactic protein-1, which play a role in the pathophysiology of obesity and MetS. Reduction of calories, exercise, and nutraceutical and pharmacological agents can modulate TLRs. CONCLUSIONS: In this review, we present evidence for a pivotal role of TLR-induced inflammation in both obesity and MetS and speculate that targeting these TLRs can forestall their adverse sequelae of diabetes and cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Tsukumo, D. M. L., Carvalho-Filho, M. A., Carvalheira, J. B. C., Prada, P. O., Hirabara, S. M., Schenka, A. A., Araújo, E. P., Vassallo, J., Curi, R., Velloso, L. A., et al. (2007) · Diabetes · doi:10.2337/db06-1595 · Cited by 826
RetractedAlberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5
Vijay-Kumar, M., Aitken, J. D., Carvalho, F. A., Cullender, T. C., Mwangi, S., Srinivasan, S., Sitaraman, S. V., Knight, R., Ley, R. E., & Gewirtz, A. T. (2010) · Science · doi:10.1126/science.1179721 · Cited by 2,068
Wildman, R. P. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1617 · Cited by 1,618
Creely, S. J., McTernan, P. G., Kusminski, C. M., Fisher, F. M., Da Silva, N. F., Khanolkar, M., Evans, M., Harte, A. L., & Kumar, S. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00302.2006 · Cited by 1,043
Assessing Adiposity: A Scientific Statement From the American Heart Association
Cornier, M.-A., Després, J.-P., Davis, N., Grossniklaus, D. A., Klein, S., Lamarche, B., Lopez-Jimenez, F., Rao, G., St-Onge, M.-P., Towfighi, A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318233bc6a · Cited by 945
High mobility group box 1 protein interacts with multiple Toll-like receptors
Park, J. S., Gamboni-Robertson, F., He, Q., Svetkauskaite, D., Kim, J.-Y., Strassheim, D., Sohn, J.-W., Yamada, S., Maruyama, I., Banerjee, A., et al. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00401.2005 · Cited by 932
Boden, G. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.06.007 · Cited by 853
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · Cited by 852
Obesity, Diabetes, and Gut Microbiota
Musso, G., Gambino, R., & Cassader, M. (2010) · Diabetes Care · doi:10.2337/dc10-0556 · Cited by 665
The gut microbiota, obesity and insulin resistance
Shen, J., Obin, M. S., & Zhao, L. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.11.001 · Cited by 599
Metabolically Healthy Obesity and Risk of All-Cause and Cardiovascular Disease Mortality
Hamer, M., & Stamatakis, E. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3475 · Cited by 564
Mozumdar, A., & Liguori, G. (2011) · Diabetes Care · doi:10.2337/dc10-0879 · Cited by 551
McArdle, M. A., Finucane, O. M., Connaughton, R. M., McMorrow, A. M., & Roche, H. M. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00052 · Cited by 532
Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes
Song, M. J., Kim, K. H., Yoon, J. M., & Kim, J. B. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.170 · Cited by 453
Miller, Y. I., Viriyakosol, S., Binder, C. J., Feramisco, J. R., Kirkland, T. N., & Witztum, J. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209634200 · Cited by 399
Elevated Toll-Like Receptor 4 Expression and Signaling in Muscle From Insulin-Resistant Subjects
Reyna, S. M., Ghosh, S., Tantiwong, P., Meka, C. S. R., Eagan, P., Jenkinson, C. P., Cersosimo, E., DeFronzo, R. A., Coletta, D. K., Sriwijitkamol, A., et al. (2008) · Diabetes · doi:10.2337/db08-0038 · Cited by 388
Gut microbiota, enteroendocrine functions and metabolism
Cani, P. D., Everard, A., & Duparc, T. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.09.008 · Cited by 378
Toll-like receptors: linking inflammation to metabolism
Könner, A. C., & Brüning, J. C. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.08.007 · Cited by 331
Metabolically Healthy Obesity and Risk of Mortality
Hinnouho, G.-M., Czernichow, S., Dugravot, A., Batty, G. D., Kivimaki, M., & Singh-Manoux, A. (2013) · Diabetes Care · doi:10.2337/dc12-1654 · Cited by 317
Moreno-Navarrete, J. M., Sabater, M., Ortega, F., Ricart, W., & Fernández-Real, J. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037160 · Cited by 300
Ghanim, H., Sia, C. L., Upadhyay, M., Korzeniewski, K., Viswanathan, P., Abuaysheh, S., Mohanty, P., & Dandona, P. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28584 · Cited by 299
Exenatide Exerts a Potent Antiinflammatory Effect
Chaudhuri, A., Ghanim, H., Vora, M., Sia, C. L., Korzeniewski, K., Dhindsa, S., Makdissi, A., & Dandona, P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1508 · Cited by 284
Miller, Y. I., Viriyakosol, S., Worrall, D. S., Boullier, A., Butler, S., & Witztum, J. L. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000159891.73193.31 · Cited by 280
Does Inflammation Determine Metabolic Health Status in Obese and Nonobese Adults?
Phillips, C. M., & Perry, I. J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2038 · Cited by 278
Exercise and Toll-like receptors
Gleeson, M., McFarlin, B. K., & Flynn, M. G. (2026) · PubMed · doi:10.22029/eir.2006.1621 · Cited by 253
Lambert, C. P., Wright, N. R., Finck, B. N., & Villareal, D. T. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00006.2008 · Cited by 249
Han, C. Y., Kargi, A. Y., Omer, M., Chan, C. K., Wabitsch, M., O'Brien, K. D., Wight, T. N., & Chait, A. (2010) · Diabetes · doi:10.2337/db09-0925 · Cited by 247
Sitagliptin Exerts an Antinflammatory Action
Makdissi, A., Ghanim, H., Vora, M., Green, K., Abuaysheh, S., Chaudhuri, A., Dhindsa, S., & Dandona, P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1544 · Cited by 241
Implication of inflammatory signaling pathways in obesity-induced insulin resistance
Tanti, J.-F., Ceppo, F., Jager, J., & Berthou, F. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00181 · Cited by 239
Suganami, T., Mieda, T., Itoh, M., Shimoda, Y., Kamei, Y., & Ogawa, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.190 · Cited by 227
Ehses, J. A., Meier, D. T., Wueest, S., Rytka, J., Boller, S., Wielinga, P. Y., Schraenen, A., Lemaire, K., Debray, S., Van Lommel, L., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1747-3 · Cited by 222
Inducible Toll‐like Receptor and NF‐κB Regulatory Pathway Expression in Human Adipose Tissue
Vitseva, O. I., Tanriverdi, K., Tchkonia, T. T., Kirkland, J. L., McDonnell, M. E., Apovian, C. M., Freedman, J., & Gokce, N. (2008) · Obesity · doi:10.1038/oby.2008.25 · Cited by 216
Tlr2 is critical for diet‐induced metabolic syndrome in a murine model
Himes, R. W., & Smith, C. W. (2010) · The FASEB Journal · doi:10.1096/fj.09-141929 · Cited by 192
Adipose Tissue Dysregulation in Patients with Metabolic Syndrome
Bremer, A. A., Devaraj, S., Afify, A., & Jialal, I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1577 · Cited by 189
Self-citationA fresh look at NASH pathogenesis. Part 1: The metabolic movers
Larter, C. Z., Chitturi, S., Heydet, D., & Farrell, G. C. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06253.x · Cited by 180
Physical Activity Status, But Not Age, Influences Inflammatory Biomarkers and Toll-Like Receptor 4
McFarlin, B. K., Flynn, M. G., Campbell, W. W., Craig, B. A., Robinson, J. P., Stewart, L. K., Timmerman, K. L., & Coen, P. M. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.4.388 · Cited by 177
The physiological regulation of toll‐like receptor expression and function in humans
Lancaster, G. I., Khan, Q., Drysdale, P., Wallace, F., Jeukendrup, A. E., Drayson, M. T., & Gleeson, M. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.081224 · Cited by 176
Ahmad, R., Al-Mass, A., Atizado, V., Al-Hubail, A., Al-Ghimlas, F., Al-Arouj, M., Bennakhi, A., Dermime, S., & Behbehani, K. (2012) · Journal of Inflammation · doi:10.1186/1476-9255-9-48 · Cited by 175
Are there still healthy obese patients?
Blüher, M. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328357f0a3 · Cited by 175
Statins Decrease Toll-Like Receptor 4 Expression and Downstream Signaling in Human CD14 + Monocytes
Methe, H., Kim, J.-O., Kofler, S., Nabauer, M., & Weis, M. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000168410.44722.86 · Cited by 172
Adipose Tissue Dysfunction in Nascent Metabolic Syndrome
Bremer, A. A., & Jialal, I. (2013) · Journal of Obesity · doi:10.1155/2013/393192 · Cited by 171
Self-citationIncreased Toll-Like Receptor Activity in Patients With Metabolic Syndrome
Jialal, I., Huet, B. A., Kaur, H., Chien, A., & Devaraj, S. (2012) · Diabetes Care · doi:10.2337/dc11-2375 · Cited by 171
Self-citationJialal, I., Devaraj, S., Kaur, H., ADAMS-HUET, B. A., & Bremer, A. A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3673 · Cited by 168
Self-citationToll-like receptors, inflammation, metabolism and obesity
Fresno, M., Álvarez, R., & Cuesta, N. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2011.562514 · Cited by 167
Wildman, R. P., Muntner, P., Reynolds, K., McGinn, A. P., Rajpathak, S., Wylie-Rosett, J., & Sowers, M. R. (2008) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000338100.83483.58 · Cited by 167
Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo
Niessner, A., Steiner, S., Speidl, W. S., Pleiner, J., Seidinger, D., Maurer, G., Goronzy, J. J., Weyand, C. M., Kopp, C. W., Huber, K., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.12.022 · Cited by 156
Caricilli, A. M., Nascimento, P. H., Pauli, J. R., Tsukumo, D. M. L., Velloso, L. A., Carvalheira, J. B. C., & Saad, M. J. A. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0354 · Cited by 143
Kim, S.-J., Choi, Y., Choi, Y., & Park, T. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.10.012 · Cited by 133
Leber, B., Tripolt, N. J., Blattl, D., Eder, M., Wascher, T. C., Pieber, T. R., Stauber, R. E., Sourij, H., Oettl, K., & Stadlbauer, V. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.103 · Cited by 125
Endogenous TLR Ligands and Autoimmunity
Wagner, H. (2006) · Advances in immunology · doi:10.1016/s0065-2776(06)91004-9 · Cited by 124
Hulsmans, M., Sinnaeve, P., der Schueren, B. V., Mathieu, C., Janssens, S. P., & Holvoet, P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1008 · Cited by 116
Functional Food Targeting the Regulation of Obesity-Induced Inflammatory Responses and Pathologies
Hirai, S., Takahashi, N., Goto, T., Lin, S., Uemura, T., Yu, R., & Kawada, T. (2010) · Mediators of Inflammation · doi:10.1155/2010/367838 · Cited by 111
Pioglitazone Inhibits Toll-Like Receptor Expression and Activity in Human Monocytes and db/db Mice
Dasu, M. R. K., Park, S., Devaraj, S., & Jialal, I. (2007) · Endocrinology · doi:10.1210/en.2008-1757 · Cited by 108
Self-citationZhao, L., Lee, J. Y., & Hwang, D. H. (2011) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00394.x · Cited by 105
Inflammatory Role of Toll-Like Receptors in Human and Murine Adipose Tissue
Poulain‐Godefroy, O., Bacquer, O. L., Plancq, P., Lecœur, C., Pattou, F. N., Frühbeck, G., & Froguel, P. (2010) · Mediators of Inflammation · doi:10.1155/2010/823486 · Cited by 102
Stoll, L. L., Denning, G. M., & Weintraub, N. L. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206778743501 · Cited by 101
Citrus flavonoid naringenin inhibits TLR2 expression in adipocytes
Yoshida, H., Watanabe, W., Oomagari, H., Tsuruta, E., Shida, M., & Kurokawa, M. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.10.003 · Cited by 99
Catalán, V., Gómez‐Ambrosi, J., Rodríguez, A., Ramírez, B., Rotellar, F., Valentí, V., Silva, C., Gil, M. J., Salvador, J., & Frühbeck, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1670 · Cited by 97
Increased Cellular and Circulating Biomarkers of Oxidative Stress in Nascent Metabolic Syndrome
Jialal, I., Devaraj, S., ADAMS-HUET, B. A., Chen, X., & Kaur, H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2498 · Cited by 94
Self-citationCandesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo
Dasu, M. R. K., Riosvelasco, A. C., & Jialal, I. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.010 · Cited by 93
Self-citationMráz, M., Lacinová, Z., Drápalová, J., Haluzíková, D., Hořínek, A., Matoulek, M., Trachta, P., Kaválková, P., Svacina, S., & Haluzík, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1858 · Cited by 90
Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-γ Agonists
Gurley, C., Nichols, J., Liu, S.-L., Phulwani, N., Esen, N., & Kielian, T. (2008) · PPAR Research · doi:10.1155/2008/453120 · Cited by 90
Jialal, I., & Kaur, H. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0258-7 · Cited by 89
Self-citationJi, Y., Liu, J., Wang, Z., Liu, N., & Gou, W. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.45 · Cited by 88
Elabd, E. M. Y., McGee, K. C., Tripathi, G., Al‐Daghri, N. M., Abdalla, M. S., Sharada, H. M., Ashour, E., Amin, A. I., Ceriello, A., O’Hare, J. P., et al. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.11.003 · Cited by 80
Inflammation and the Metabolic Syndrome
Sharma, P. (2011) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-011-0175-6 · Cited by 75
Devaraj, S., Yun, J.-M., Duncan-Staley, C. R., & Jialal, I. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcpjgzqx42biaxl · Cited by 69
de Mello, V. D., Kolehmainen, M., Pulkkinen, L., Schwab, U., Mager, U., Laaksonen, D. E., NISKANEN, L. K., Gylling, H., Atalay, M., Rauramaa, R., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1132-7 · Cited by 68
Elevated Soluble Lectin‐like Oxidized LDL Receptor‐1 (sLOX‐1) Levels in Obese Postmenopausal Women
Brinkley, T. E., Kume, N., Mitsuoka, H., Phares, D. A., & Hagberg, J. M. (2008) · Obesity · doi:10.1038/oby.2008.213 · Cited by 63
The Roles of Toll-Like Receptors in Atherosclerosis
Erridge, C. (2009) · Journal of Innate Immunity · doi:10.1159/000191413 · Cited by 60
The gut microbiota profile is associated with insulin action in humans
Sérino, M., Fernández‐Real, J. M., García‐Fuentes, E., Queipo‐Ortuño, M. I., Moreno‐Navarrete, J. M., Sánchez‐Pla, Á., Burcelin, R., & Tinahones, F. J. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0410-5 · Cited by 58
Modulation of dendritic cells and toll-like receptors by marathon running
Nickel, T., Emslander, I., Sisic, Z., David, R., Schmaderer, C., Marx, N., Schmidt‐Trucksäss, A., Hoster, E., Halle, M., Weis, M., et al. (2011) · European Journal of Applied Physiology · doi:10.1007/s00421-011-2140-8 · Cited by 54
Scholtes, V. P. W., Versteeg, D., de Vries, J. P. P. M., Hoefer, I. E., Schoneveld, A. H., Stella, P. R., Doevendans, P. A., van Keulen, K., de Kleijn, D. P. V., Moll, F. L., et al. (2011) · Clinical Science · doi:10.1042/cs20100601 · Cited by 43
To be obese—does it matter if you are metabolically healthy?
Karelis, A. D. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.181 · Cited by 41
Hardy, O. T., Kim, A., Ciccarelli, C., Hayman, L. L., & Wiecha, J. L. (2012) · Pediatric Obesity · doi:10.1111/j.2047-6310.2012.00098.x · Cited by 38
Murakami, K., Bujo, H., Unoki‐Kubota, H., & Saitō, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.039 · Cited by 37
Therapeutic role of toll-like receptor modification in cardiovascular dysfunction
Navi, A., Patel, H., Shaw, S., Baker, D., & Tsui, J. C. S. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.10.001 · Cited by 26
Inflammation and Metabolic Syndrome
Devaraj, S., Siegel, D., & Jialal, I. (2011) · Wiley eBooks · doi:10.1002/9781444347319.ch13 · Cited by 8
Self-citation
Cited by
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286
Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
Scheithauer, T. P. M., Rampanelli, E., Nieuwdorp, M., Vallance, B. A., Verchere, C. B., van Raalte, D. H., & Herrema, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571731 · Cited by 673
The crucial role and mechanism of insulin resistance in metabolic disease
Zhao, X., An, X., Yang, C., Sun, W., Ji, H., & Lian, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1149239 · Cited by 557
Toll-like receptors activation, signaling, and targeting: an overview
El-Zayat, S. R., Sibaii, H., & Mannaa, F. A. (2019) · Bulletin of the National Research Centre · doi:10.1186/s42269-019-0227-2 · Cited by 556
Collins, K. H., Herzog, W., MacDonald, G. Z., Reimer, R. A., Rios, J. L., Smith, I. C., Zernicke, R. F., & Hart, D. A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00112 · Cited by 308
Metadata
- Authors
- Jialal, I., Kaur, H., & Devaraj, S.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-01
- Volume
- 99
- Issue
- 1
- Pages
- 39-48
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2156769836
- Cited by
- 285
- References
- 84
- FWCI
- 11.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.